Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by O. de Weerdt
Reduced Relapse Rate in Upfront Tandem Autologous/Reduced-Intensity Allogeneic Transplantation in Multiple Myeloma Only Results in Borderline Non-Significant Prolongation of Progression-Free but Not Overall Survival
Haematologica
Hematology
Related publications
GvHD-free, Relapse-Free Survival After Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation in Older Patients With Myeloid Malignancies
Bone Marrow Transplantation
Transplantation
Hematology
Reduced Progression-Free Survival in Elderly Patients Receiving Intensification With Autologous Peripheral Blood Stem Cell Reinfusion for Multiple Myeloma
Bone Marrow Transplantation
Transplantation
Hematology
The Current Status of Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Reduced-Intensity Allogeneic Transplantation Provides High Event-Free and Overall Survival in Patients With Advanced Indolent B Cell Malignancies: CALGB 109901
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Autologous Transplantation Followed Closely by Reduced-Intensity Allogeneic Transplantation as Consolidative Immunotherapy in Advanced Lymphoma Patients: A Feasibility Study
Bone Marrow Transplantation
Transplantation
Hematology
Validation of a New Integrated Prognostic Score to Predict Non-Relapse Mortality in Patients Undergoing Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
Impact of MiRSNPs on Survival and Progression in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
Clinical Cancer Research
Cancer Research
Oncology
Autologous Stem Cell Transplantation in First Remission Significantly Prolongs Progression-Free and Overall Survival in Mantle Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
The Impact of Donor Gender on Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Reduced Relapse Risk in Female to Male Transplants
Bone Marrow Transplantation
Transplantation
Hematology
